Comprehensive Biomarker Discovery Platform Reveals Qualified MRM Assay for Prediction of INF/Ribavirin Treatment Response in Hepatitis C Patients

The current standard of care for chronic Hepatitis C (CHC) results in sustained viral response in only half of patients and also has significant side effects. Improved pre-treatment clinical predictors of response are needed to individualize treatment and select individuals most appropriate for new...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dubois, L.G., Patel, K., Lucas, J.E., McCarthy, J., McHutchison, J.G., Moseley, M.A., Thompson, J.W.
Médium: Artigo
Jazyk:Inglês
Vydáno: Association of Biomolecular Resource Facilities 2011
Témata:
Poster Session Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186590/
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky